Contents of Supplement 6.5 A vertical line in the margin indicates where part of a text has been revised or corrected. A horizontal line in the marginindicates where part of a text has been deleted. It is to be emphasised that these indications, which are not necessarilyexhaustive, are given for information and do not form an official part of the texts. Editorial changes are not indicated. Individual copies of texts will not be supplied.NEW TEXTS GENERAL CHAPTERS Monographs
2.9.45. Wettability of porous solids including powders
Bitter-fennel herb oil (2380)Ceftazidime pentahydrate with sodium carbonate for
MONOGRAPHS The monographs below appear for the first time in theEuropean Pharmacopoeia. They will be implemented on1 July 2009 at the latest. Vaccines for veterinary use
Porcine enzootic pneumonia vaccine (inactivated) (2448)
Radiopharmaceutical preparations
Medronic acid for radiopharmaceutical preparations (2350)
REVISED TEXTS GENERAL CHAPTERS
Carboplatin (1081)Ceftazidime pentahydrate (1405)
2.6.12. Microbiological examination of non-sterile products:
Cyproheptadine hydrochloride (0817)Desmopressin (0712)
2.6.13. Microbiological examination of non-sterile products:
Dimenhydrinate (0601)Etacrynic acid (0457)
2.6.24. Avian viral vaccines: tests for extraneous agents in
Frangula bark dry extract, standardised (1214)Ginkgo leaf (1828)
2.6.26. Test for anti-D antibodies in human immunoglobulin
2.9.34. Bulk density and tapped density of powders
Reagents (new, revised, corrected)
5.2.5. Substances of animal origin for the production of
immunological veterinary medicinal products
Methylergometrine maleate (1788)Mirtazapine (2338)
MONOGRAPHS The monographs below have been technically revised since Paraffin, white soft (1799)
their last publication in the European Pharmacopoeia.They will be implemented on 1 July 2009.
Penicillamine (0566)Pentaerythrityl tetranitrate, diluted (1355)
General monographs Vaccines for veterinary use
Infectious chicken anaemia vaccine (live) (2038)
Homoeopathic preparations
Herbal drugs for homoeopathic preparations (2045)
Monographs Contents of Supplement 6.5 CORRECTED TEXTS The texts below have been corrected and are republished in their entirety. These corrections are to be taken into accountfrom the publication date of Supplement 6.5 (1 January 2009). GENERAL CHAPTERS
Foscarnet sodium hexahydrate (1520)Imipramine hydrochloride (0029)
MONOGRAPHS
Interferon beta-1a concentrated solution (1639)
Monographs
Bifonazole (1395)Bismuth subgallate (1493)
Cholecalciferol concentrate (oily form) (0575)
Cholecalciferol concentrate (powder form) (0574)
Cholecalciferol concentrate (water-dispersible form) (0598)
TEXTS WHOSE TITLE HAS CHANGED The title of the following texts has been changed in Supplement 6.5.GENERAL CHAPTERS
5.2.5. Substances of animal origin for the production of immunological veterinary medicinal products (previouslySubstances of animal origin for the production of veterinary vaccines)MONOGRAPHS Monographs Ceftazidime pentahydrate (1405) (previously Ceftazidime) DELETED TEXTS The following texts are deleted as of 1 April 2009. GENERAL CHAPTERS 2.9.15. Apparent volume MONOGRAPHS Monographs Lindane (0772) The following text was deleted on 1 April 2008. MONOGRAPHS Vaccines for human use Pertussis vaccine (0160)
__________________________ SANOFI-AVENTIS, SANOFI-SYNTHELABO, INC., AND BRISTOL-MYERS SQUIBB SANOFI PHARMACEUTICALS HOLDING PARTNERSHIP, APOTEX INC. AND APOTEX CORP., __________________________ __________________________ Appeal from the United States Court for the Southern District of New York in Case No. 02-CV-2255, Judge ___________________________ ____________
PREDNISOLONE SODIUM PHOSPHATE Prednisolone sodium phosphate oral solutionpneumonias; fulminating or disseminated pulmonarydisseminated infection is not known. The contribution Endocrine: Drug-induced secondary adrenocortical ORAL SOLUTION (25 mg prednisolone base (25 mg prednisolone per 5 mL) produces a 14%tuberculosis when used concurrently with appropriateof the underlying disease a